|
Male sex
|
28(80.0)
|
21(72.4)
|
0.79
|
|
Age, mean years ± SD
|
63 ± 13.8
|
63 ± 18.9
|
0.988
|
|
Ward
|
|
ICU
|
17(48.6)
|
17(58.6)
|
0.68
|
|
Medicine
|
6(17.1)
|
2(6.9)
|
0.45
|
|
Surgery
|
12(34.3)
|
10(34.5)
|
>0.99
|
|
Transferred from another hospital
|
15(42.9)
|
13(44.8)
|
0.92
|
|
Total length of stay in any hospital before isolation of KPC-KP,
| | | |
|
mean days ± SD
|
18.7 ± 15.1
|
16.2 ± 15.0
|
0.525
|
|
Total length of stay until discharge or death, mean days ± SD
|
36.1 ± 22.2
|
35.6 ± 22.4
|
0.94
|
|
Route of acquisition of KPC-KP
| | |
0.203
|
|
Imported
|
4(11.4)
|
7(24.1)
|
--
|
|
Acquired in our hospital
|
31(88.6)
|
22(75.9)
|
--
|
|
Site of KPC-KP isolation
|
|
Bronchial secretion
|
15(42.9)
|
12(41.4)
|
>0.99
|
|
Blood
|
6(17.1)
|
10(34.5)
|
0.27
|
|
Drainage
|
7(20.0)
|
6(20.7)
|
>0.99
|
|
Urine
|
4(11.4)
|
1(3.4)
|
0.38
|
|
Cerebrospinal fluid
|
2(5.7)
|
0
|
--
|
|
Pus
|
1(2.9)
|
0
|
--
|
|
Infection
|
31(88.6)
|
28(96.6)
|
0.37
|
|
Median APACHEII score
|
17(2–37)
|
16(2–35)
|
0.129
|
|
Median Charlson score
|
2(0–10)
|
2(0–5)
|
0.233
|
|
Invasive procedures
|
|
Surgery within a month
|
16(45.7)
|
15(51.7)
|
0.83
|
|
Mechanical ventilation
|
18(51.4)
|
18(62.1)
|
0.68
|
|
Renal replacement therapy
|
11(31.4)
|
9(31.0)
|
>0.99
|
|
Drainage catheters
|
33(94.3)
|
20(68.9)
|
0.46
|
|
Total times of bed transfer during this hospitalization, mean times ± SD
|
2.54 ± 1.31
|
2.52 ± 1.38
|
0.94
|
|
Total times of bed transfer after KPC-KP isolation, mean times ± SD
|
1.57 ± 0.95
|
1.66 ± 0.94
|
0.72
|
|
Antibiotic therapy during the last month
|
|
Piperacillin-tazobactam
|
6(17.1)
|
5(17.2)
|
>0.99
|
|
Third-generation cephalosporins
|
21(60.0)
|
21(72.4)
|
0.69
|
|
Carbapenems
|
21(60.0)
|
13(44.8)
|
0.53
|
|
Quinolones
|
10(28.6)
|
3(10.3)
|
0.22
|
|
Fosfomycin
|
2(5.7)
|
1(3.4)
|
>0.99
|
|
Aminoglycosides
|
0
|
1(3.4)
|
--
|
|
Minocycline
|
1(2.9)
|
0
|
--
|
|
Crude mortality
|
8(22.9)
|
8(27.6)
|
0.77
|
|
Attributable mortality
|
6(19.4)a
|
5(17.9)
|
0.88
|
